CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
DIAMARK focuses on understanding diabetic neuropathy and identifying reliable biomarkers for gastrointestinal complications. The project aims to develop and validate new biomarkers through advanced testing methods, enhancing the management of diabetes-related disorders.
DIAMARK is focused on analysing the pathophysiology of diabetic neuropathy and to determine better biomarkers of the complications and approaches for intervention.
Due to lack of standardisation, there are no accepted biomarkers to evaluate the neuropathy and its involvement in the GI tract.
Diabetes mellitus (DM) is one of the most common endocrine disorders affecting almost 6% (app. 246 million people) worldwide (http://www.idf.org). DM is a chronic disease requiring lifelong attention in orde…
AALBORG SYGEHUS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UGOT - GOETEBORGS UNIVERSITET/UNIVERSITY OF GOTHENBURG
Sweden, Goeteborg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Ireland, Kilcullen Co Kildare
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
